Long-term follow-up of the Minder implanted EEG system for epilepsy care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational long‑term follow‑up of participants who previously received the implanted Minder sub‑scalp EEG device in the DETECT program. The study collects periodic information on general wellbeing, healthcare use, and participants' experience using Minder data after an actionable event or completion of the 6‑month DETECT visit. Participants remain under the care of their treating physicians while study staff document how Minder data are used in routine clinical decision‑making. The Minder System has FDA De Novo classification and is being followed in real‑world settings at participating centers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participant met all inclusion criteria, was enrolled in the DETECT study, and received the Minder device
* Participant completed the DETECT study by receiving an actionable event or by completing the 6-month follow-up visit
* Participant continues to have the Minder device implanted
* Participant must continue to meet relevant DETECT study inclusion criteria

Exclusion Criteria:

* Participant meets any relevant DETECT study exclusion criteria including needing treatments or assessments that are not indicated with the Minder System like Magnetic Resonance Imaging (MRI)

Where it's running

• UAB Epilepsy Center
  Birmingham, Alabama, United States Recruiting
• Mayo Clinic - Arizona
  Phoenix, Arizona, United States Recruiting
• Stanford
  Palo Alto, California, United States Recruiting
• Stanford
  Palo Alto, California, United States Recruiting
• UC San Diego Health
  San Diego, California, United States Recruiting
• Yale School of Medicine
  New Haven, Connecticut, United States Recruiting

Study contacts

• Study coordinator: Epiminder, Director of Clinical Trials
• Email: clinical@epiminder.com
• Phone: 800-717-3185

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

  This study tests whether low intensity focused ultrasound can help reduce seizures in adults with drug‑resistant epilepsy.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07680842

• Minder sub‑scalp EEG to improve diagnosis and care for epilepsy

  This test will see if the Minder sub‑scalp EEG device gives more reliable, long‑term seizure data than usual care for people with drug‑resistant epilepsy whose seizures aren't well captured by standard EEG.

  Recruiting at 23 sites Epiminder America, Inc. · Birmingham, Alabama and 22 other locations · NCT07110337

• RAP-219 long-acting injectable safety and PK study in healthy adults

  This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.

  Recruiting Phase 1 Rapport Therapeutics Inc. · Adelaide · NCT07923097

• Why People with Epilepsy Get More Infections

  This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.

  Recruiting University of Aberdeen · Aberdeen · NCT07903168

• Long-Term Epilepsy Outcomes in Children After Perinatal Stroke

  This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07898397

• Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy

  This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens, Picardie · NCT07888543

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.